DeepMed Research

RUTGERS, THE STATE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer

Completed

Conditions: Colorectal Cancer

First Posted Date: 2009-08-27

Last Posted Date: 2019-09-10

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 222

Registration Number: NCT00966667

Locations: 🇺🇸
Overlook Medical Center, Summit, New Jersey, United States
🇺🇸
Cooper Hospital/University Medical Center, Camden, New Jersey, United States
🇺🇸
JFK Medical Center in Edison, Edison, New Jersey, United States

and more 11 locations

Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Early Phase 1

Completed

Conditions: Melanoma (Skin)

Interventions: Drug: hydroxychloroquine

First Posted Date: 2009-08-20

Last Posted Date: 2022-09-07

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 20

Registration Number: NCT00962845

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery

Phase 2

Completed

Conditions: Liver Cancer

Interventions: Other: laboratory biomarker analysis

First Posted Date: 2009-07-30

Last Posted Date: 2014-01-14

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 20

Registration Number: NCT00949182

Locations: 🇺🇸
Rutgers University Hospital, Newark, New Jersey, United States

Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome

Not Applicable

Terminated

Conditions: Leukemia
Lymphoma
Neuroblastoma
Testicular Germ Cell Tumor
Breast Cancer
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Chronic Myeloproliferative Disorders
Myelodysplastic/Myeloproliferative Neoplasms
Ovarian Cancer

Interventions: Dietary Supplement: Lactobacillus rhamnosus GG

First Posted Date: 2009-07-24

Last Posted Date: 2017-02-03

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 30

Registration Number: NCT00946283

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial

Not Applicable

Completed

Conditions: Childhood Cancers

Interventions: Behavioral: Behavioral intervention sessions
Other: DVD and pamphlet
Other: CD-ROM
Other: Respite care

First Posted Date: 2009-07-15

Last Posted Date: 2016-03-10

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 212

Registration Number: NCT00939380

Locations: 🇺🇸
Childrens Hospital Los Angeles, Los Angeles, California, United States
🇺🇸
Columbia University, New York, New York, United States
🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

and more 2 locations

Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca

Phase 1

Terminated

Conditions: Breast Cancer

Interventions: Drug: everolimus
Drug: abraxane

First Posted Date: 2009-07-08

Last Posted Date: 2023-09-18

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 27

Registration Number: NCT00934895

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey (Hamilton), Hamilton, New Jersey, United States
🇺🇸
Cooper Hospital/University Medical Center, Camden, New Jersey, United States
🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Effects of Dexmedetomidine on Tourniquet Pain Associated With Lower Extremity Surgeries Under General Anesthesia

Phase 4

Withdrawn

Conditions: Orthopedic/Podiatry Procedures

Interventions: Drug: Dexmedetomidine Hcl infusion
Drug: normal saline

First Posted Date: 2009-07-03

Last Posted Date: 2015-04-24

Lead Sponsor: Rutgers, The State University of New Jersey

Registration Number: NCT00932386

Locations: 🇺🇸
New Jersey Medical School, Newark, New Jersey, United States

Radiation Therapy in Treating Women With Early Stage Breast Cancer

Phase 2

Active, not recruiting

Conditions: Breast Cancer

Interventions: Radiation: External beam boost
Radiation: whole breast irradiation

First Posted Date: 2009-05-29

Last Posted Date: 2023-08-03

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 200

Registration Number: NCT00909909

Locations: 🇺🇸
RWJBarnabas Health - Robert Wood Johnson University Hospital, Somerset, New Jersey, United States
🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Vitamin E Supplements in Treating Patients Undergoing Surgery for Colorectal Cancer

Phase 1

Completed

Conditions: Colorectal Cancer

Interventions: Dietary Supplement: vitamin E
Other: laboratory biomarker analysis

First Posted Date: 2009-05-21

Last Posted Date: 2014-09-30

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 14

Registration Number: NCT00905918

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Studying Tumor Tissue Samples From Patients With Early-Stage Breast Cancer

Withdrawn

Conditions: Breast Cancer

First Posted Date: 2009-05-12

Last Posted Date: 2015-05-29

Lead Sponsor: Rutgers, The State University of New Jersey

Registration Number: NCT00899639

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy